Myriad Genetics (MYGN) Cash from Operations (QoQ) (2009 - 2026)
Myriad Genetics (MYGN) Cash from Operations (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Myriad Genetics | 300.99 Mn | 185.79 Mn | 127.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.13% |
| Mar 31, 2026 | -248.11% |
| Dec 31, 2025 | -49.76% |
| Sep 30, 2025 | 255.15% |
| Jun 30, 2025 | 16.56% |
| Mar 31, 2025 | -346.97% |
| Dec 31, 2024 | 842.86% |
| Sep 30, 2024 | -73.08% |
| Jun 30, 2024 | 113.98% |
| Mar 31, 2024 | 66.00% |
| Dec 31, 2023 | -147.51% |
| Sep 30, 2023 | -2,355.56% |
| Jun 30, 2023 | 97.29% |
| Mar 31, 2023 | -354.79% |
| Dec 31, 2022 | -160.71% |
| Sep 30, 2022 | 94.37% |
| Jun 30, 2022 | -6.88% |
| Mar 31, 2022 | -389.47% |
| Dec 31, 2021 | 75.83% |
| Sep 30, 2021 | -793.18% |